Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

SS Innovations International (SSII) Non-Current Deferred Tax Liability (2022 - 2024)

SS Innovations International recorded quarterly Non-Current Deferred Tax Liability of $6582.0 in Q1 2024, up 132.14% quarter-over-quarter from -$20482.0 in Q4 2023.

SS Innovations International's Non-Current Deferred Tax Liability history runs 3 years deep, the most recent figure standing at $6582.0 for Q1 2024.

  • In Q1 2024, Non-Current Deferred Tax Liability changed N/A year-over-year to $6582.0; the TTM figure through Mar 2024 stood at $6582.0 (changed N/A YoY), while the FY2023 annual figure was -$20482.0, down 199.44% from the prior year.
  • Non-Current Deferred Tax Liability came in at $6582.0 for Q1 2024 at SS Innovations International, up from -$20482.0 in the prior quarter.
  • In the past five years, Non-Current Deferred Tax Liability ranged from a high of $20597.0 in Q4 2022 to a low of -$20482.0 in Q4 2023.
  • A 3-year average of $2232.3 and a median of $6582.0 in 2024 frame the typical range for Non-Current Deferred Tax Liability.
  • On a YoY basis, Non-Current Deferred Tax Liability climbed as much as 199.44% in 2023 and fell as far as 199.44% in 2023.
  • SS Innovations International's Non-Current Deferred Tax Liability stood at $20597.0 in 2022, then slumped by 199.44% to -$20482.0 in 2023, then jumped by 132.14% to $6582.0 in 2024.
  • According to Business Quant data, Non-Current Deferred Tax Liability over the past three periods registered $6582.0, -$20482.0, and $20597.0 for Q1 2024, Q4 2023, and Q4 2022 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn
10 SS Innovations International 770.31 Mn 746.70 Mn 5.33 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2024 6,582.00
Mar 31, 2024 6,582.00
Dec 31, 2023 -20,482.00
Dec 31, 2023 -20,482.00
Dec 31, 2022 20,597.00
Dec 31, 2022 20,597.00